Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05911997 · ClinicalTrials.gov registry record · Phase 1
MTC Versus FMT in for RCDI
A Phase 1 study of Clostridiodies Difficile Infections, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05911997 is a Phase 1 study of Clostridiodies Difficile Infections that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05911997, a Phase 1 study of Clostridiodies Difficile Infections, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigating four different treatment of MTC or FMT
Conditions Studied
Interventions
- DRUG MTC 01
- DRUG Fecal Microbiota Transplantation (FMT)
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-08 |
| Est. Completion | 2026-07-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05911997
The ClinicalTrials.gov registry entry for NCT05911997 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Clostridiodies Difficile Infections appearing as the primary indexed condition, and to 2 interventions - of which MTC 01 is the first listed.
NCT05911997 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05911997 about?
NCT05911997 is a clinical study titled "MTC Versus FMT in for RCDI". Investigating four different treatment of MTC or FMT
What is the current status of trial NCT05911997?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2024-01-08. Estimated completion is 2026-07-25.
What conditions does trial NCT05911997 study?
This clinical trial studies the following conditions: Clostridiodies Difficile Infections.
What interventions are being tested in trial NCT05911997?
The interventions under investigation include: MTC 01 (DRUG), Fecal Microbiota Transplantation (FMT) (DRUG).
Who is sponsoring clinical trial NCT05911997?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05911997 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.